206 related articles for article (PubMed ID: 35215859)
1. Induction of Hepatitis E Virus Anti-ORF3 Antibodies from Systemic Administration of a Muscle-Specific Adeno-Associated Virus (AAV) Vector.
Maurer L; El Andari J; Rapti K; Spreyer L; Steinmann E; Grimm D; Dao Thi VL
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215859
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies raised against the ORF3 protein of hepatitis E virus (HEV) can capture HEV particles in culture supernatant and serum but not those in feces.
Takahashi M; Yamada K; Hoshino Y; Takahashi H; Ichiyama K; Tanaka T; Okamoto H
Arch Virol; 2008; 153(9):1703-13. PubMed ID: 18679765
[TBL] [Abstract][Full Text] [Related]
3. Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus.
Mazalovska M; Kouokam JC
Viruses; 2020 Jul; 12(8):. PubMed ID: 32751441
[TBL] [Abstract][Full Text] [Related]
4. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.
Renoux VM; Fleury MJ; Bousarghin L; Gaitan J; Sizaret PY; Touzé A; Coursaget P
Vaccine; 2008 Dec; 26(51):6602-7. PubMed ID: 18835319
[TBL] [Abstract][Full Text] [Related]
5. Valuable antibody detection method for classifying hepatitis E virus genotypes.
Zhao C; Geng Y; Huang W; Ma H; Wang Y
J Med Virol; 2018 Jan; 90(1):142-147. PubMed ID: 28817198
[TBL] [Abstract][Full Text] [Related]
6. Antigenic Characterization of ORF2 and ORF3 Proteins of Hepatitis E Virus (HEV).
Pezzoni G; Stercoli L; Pegoiani E; Brocchi E
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372591
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis E virus ORF3 antigens derived from genotype 1 and 4 viruses are detected with varying efficiencies by an anti-HEV enzyme immunoassay.
Ma H; Song X; Harrison TJ; Zhang H; Huang W; Wang Y
J Med Virol; 2011 May; 83(5):827-32. PubMed ID: 21360543
[TBL] [Abstract][Full Text] [Related]
8. [Dynamics of anti-HEV ORF2, ORF3, IgM and IgG in serial sera of patients with hepatitis E and their clinical significance].
Ruan B; Zhuang H; Ma Y
Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):498-500. PubMed ID: 10923456
[TBL] [Abstract][Full Text] [Related]
9. A Proline-Rich Domain in the Genotype 4 Hepatitis E Virus ORF3 C-Terminus Is Crucial for Downstream V105DLP108 Immunoactivity.
Wang H; Ji F; Liang H; Gu H; Ning Z; Liu R; Zhang G
PLoS One; 2015; 10(7):e0133282. PubMed ID: 26177202
[TBL] [Abstract][Full Text] [Related]
10. A new artificial antigen of the hepatitis E virus.
Ulanova TI; Obriadina AP; Talekar G; Burkov AN; Fields HA; Khudyakov YE
J Immunoassay Immunochem; 2009; 30(1):18-39. PubMed ID: 19117200
[TBL] [Abstract][Full Text] [Related]
11. A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice.
Xiang K; Kusov Y; Ying G; Yan W; Shan Y; Jinyuan W; Na Y; Yan Z; Hongjun L; Maosheng S
Viruses; 2017 Sep; 9(9):. PubMed ID: 28914805
[TBL] [Abstract][Full Text] [Related]
12. Efficient formation and maintenance of humoral and CD4 T-cell immunity targeting the viral capsid in acute-resolving hepatitis E infection.
Csernalabics B; Marinescu MS; Maurer L; Kelsch L; Werner J; Baumann K; Zoldan K; Panning M; Reuken P; Bruns T; Bengsch B; Neumann-Haefelin C; Hofmann M; Thimme R; Dao Thi VL; Boettler T
J Hepatol; 2024 Apr; 80(4):564-575. PubMed ID: 38154741
[TBL] [Abstract][Full Text] [Related]
13. Open reading frame 3 protein of hepatitis E virus: Multi-function protein with endless potential.
Yang YL; Nan YC
World J Gastroenterol; 2021 May; 27(20):2458-2473. PubMed ID: 34092969
[TBL] [Abstract][Full Text] [Related]
14. Varying abilities of recombinant polypeptides from different regions of hepatitis E virus ORF2 and ORF3 to detect anti-HEV immunoglobulin M.
Ma H; Song X; Li Z; Harrison TJ; Zhang H; Huang W; Hao W; Kong W; Wang Y
J Med Virol; 2009 Jun; 81(6):1052-61. PubMed ID: 19382255
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice.
Deshmukh TM; Lole KS; Tripathy AS; Arankalle VA
Vaccine; 2007 May; 25(22):4350-60. PubMed ID: 17459540
[TBL] [Abstract][Full Text] [Related]
16. A plant-based transient expression system for the rapid production of highly immunogenic Hepatitis E virus-like particles.
Mardanova ES; Takova KH; Toneva VT; Zahmanova GG; Tsybalova LM; Ravin NV
Biotechnol Lett; 2020 Nov; 42(11):2441-2446. PubMed ID: 32875477
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the Quasi-Enveloped Hepatitis E Virus Particles Released by the Cellular Exosomal Pathway.
Nagashima S; Takahashi M; Kobayashi T; ; Nishizawa T; Nishiyama T; Primadharsini PP; Okamoto H
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878075
[TBL] [Abstract][Full Text] [Related]
18. [The preliminary analysis of the recognition epitopes of anti-HEV monoclonal antibodies on HEV ORF2].
Xiong JH; Guo QS; Ge SX; Gu Y; Chen YX; Miao J; Du HL; Shi WG; Zhang J; Xia NS
Bing Du Xue Bao; 2008 Jun; 24(2):83-7. PubMed ID: 18533338
[TBL] [Abstract][Full Text] [Related]
19. A Linear Surface Epitope in a Proline-Rich Region of ORF3 Product of Genotype 1 Hepatitis E Virus.
Yang Y; Lin S; Nan Y; Ma Z; Yang L; Zhang Y
Viruses; 2016 Aug; 8(8):. PubMed ID: 27548202
[TBL] [Abstract][Full Text] [Related]
20. Recombinant Hepatitis E virus like particles can function as RNA nanocarriers.
Panda SK; Kapur N; Paliwal D; Durgapal H
J Nanobiotechnology; 2015 Jun; 13():44. PubMed ID: 26104584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
